AVENUE SOLUTIONS for MERCK & CO. INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues relating to the further development of antibiotics and antimicrobials for serious and unmet medical needs; Antibiotics/stewardship; Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act (DISARM Act); Value of prescription drugs; Issues related to Medicare Parts B and D; Medicaid AMP (Average Manufacturer Price) cap; H.R.1319, American Rescue Plan Act of 2021 (P.L. 117-2); Continued monitoring of Consolidated Appropriations Act, 2021 (P.L. 116-260)
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRACY SPICER | — |
Health Issues HCR
Antibiotics/stewardship; Value of prescription drugs; Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act (DISARM Act) H.R. 1319, American Rescue Plan Act of 2021 (P.L. 117-2) Continued monitoring of Consolidated Appropriations Act, 2021 (P.L. 116-260)
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRACY SPICER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.